LAUSR

Baumann, M.A., Paul, C.C., Lemley-Gillespie, S., Oyster, M. & Gomez-Cambronero, J. (2001) Modulation of MEK activity during G-CSF signalling alters proliferative versus differentiative balancing. American Journal of Hematology, 68, 99–105. Billio, A., Venturi, R., Morello, E., Rosanelli, C., Pescota, N. & Coser, P. (2001) Chronic neutrophilic leukemia evolving from polycythemia vera with multiple chromosome rearrangements: a case report. Haematologica, 86, 1225–1226. Castelli, R., Cugno, M., Gianelli, U., Pancrazzi, A. & Vannucchi, A.M. (2015) Neutrophilic progression in a case of polycythemia vera mimicking chronic neutrophilic leukemia: clinical and molecular characterization. Pathology Research & Practice, 211, 341–343. Ferrer-Mar ın, F., Bellosillo, B., Mart ınez-Avil es, L., Soler, G., Carbonell, P., Luengo-Gil, G., Caparr os, E., Torregrosa, J.M., Besses, C. & Vicente, V. (2013) Leukemic transformation driven by an ASXL1 mutation after a JAK2 V617Fpositive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing. Journal of Hematology & Oncology, 6, 68. Higuchi, T., Oba, R., Endo, M., Harada, H., Mori, H., Niikura, H., Omine, M. & Fujita, K. (1999) Transition of polycythemia vera to chronic neutrophilic leukemia. Leukemia & Lymphoma, 33, 203–206. Khanna, V., Pierce, S.T., Dao, K.H., Tognon, C.E., Hunt, D.E., Junio, B., Tyner, J.W. & Druker, B. (2015) Durable disease control with MEK inhibition in a patient with NRAS-mutated atypical chronic myeloid leukemia. Cureus, 7, e414. Maxson, J.E. & Tyner, J.W. (2017) Genomics of chronic neutrophilic leukemia. Blood, 129, 715– 722. Meggendorfer, M., Haferlach, T., Alpermann, T., Jeromin, S., Haferlach, C., Kern, W. & Schnittger, S. (2014) Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia. Haematologica, 99, e244–e246. Tenedini, E., Bernardis, I., Artusi, V., Roncaglia, E., Guglielmelli, P., Pieri, L., Bogani, C., Biamonte, F., Rotunno, G., Mannarrelli, C., Bianchi, E., Pancrazzi, A., Fanelli, T, Malagoli Tagliazucchi, G., Ferrari, S., Manfredini, R, Vannucchi, A.M., Tagliafico, E. & on behalf of AGIMM investigators. (2014) Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms. Leukemia, 28, 1052–1059. Vannucchi, A.M. & Harrison, C.N. (2017) Emerging treatments for classical myeloproliferative neoplasms. Blood, 129, 693–703.